AUVIZRI Trademark

Trademark Overview


On Monday, February 6, 2023, a trademark application was filed for AUVIZRI with the United States Patent and Trademark Office. The USPTO has given the AUVIZRI trademark a serial number of 97782421. The federal status of this trademark filing is REGISTERED as of Tuesday, April 23, 2024. This trademark is owned by Glaxo Group Limited. The AUVIZRI trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, and immune system related diseases and disorders; all of the foregoing excluding pharmaceutical preparations for the treatment of psychiatric related diseases and disorders, including depression
auvizri

General Information


Serial Number97782421
Word MarkAUVIZRI
Filing DateMonday, February 6, 2023
Status700 - REGISTERED
Status DateTuesday, April 23, 2024
Registration Number7363834
Registration DateTuesday, April 23, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2023

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, and immune system related diseases and disorders; all of the foregoing excluding pharmaceutical preparations for the treatment of psychiatric related diseases and disorders, including depression

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 24, 2023
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage, GB SG12NY

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage, GB SG12NY

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage, GB SG12NY

Trademark Events


Event DateEvent Description
Thursday, February 9, 2023NEW APPLICATION ENTERED
Friday, February 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 30, 2023ASSIGNED TO EXAMINER
Friday, November 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 10, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, November 16, 2023ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, November 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 4, 2024ASSIGNED TO PETITION STAFF
Tuesday, December 19, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, January 5, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, February 2, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, March 5, 2024CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Friday, March 15, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, April 23, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, March 13, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, April 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED